Login to Your Account



Xenova Gets US$1.5M From Sale Of KSB's Monoclonal Business

By Nuala Moran


Wednesday, January 7, 2004
No Abstract

To continue reading subscribe now to BioWorld International

Learn More about BioWorld International

Already a subscriber? Sign In or Buy now to activate your subscription